| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
21,237 |
9,223 |
$704K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
5,440 |
4,568 |
$194K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
6,783 |
5,646 |
$80K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
5,843 |
2,539 |
$69K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
885 |
729 |
$43K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
475 |
461 |
$35K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,071 |
1,714 |
$30K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
400 |
388 |
$30K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,375 |
1,303 |
$30K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
3,058 |
1,448 |
$26K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,209 |
3,381 |
$23K |
| 99000 |
|
2,354 |
2,121 |
$21K |
| 99050 |
|
1,095 |
991 |
$13K |
| 87807 |
|
1,224 |
985 |
$11K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
158 |
150 |
$11K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
198 |
187 |
$11K |
| S8301 |
Infection control supplies, not otherwise specified |
2,225 |
1,847 |
$10K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
143 |
133 |
$10K |
| 92567 |
|
680 |
656 |
$7K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
79 |
74 |
$3K |
| 80176 |
|
344 |
322 |
$3K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
358 |
316 |
$3K |
| 86318 |
|
185 |
178 |
$2K |
| 0071A |
|
56 |
44 |
$1K |
| 87428 |
|
66 |
65 |
$1K |
| 0072A |
|
32 |
30 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
84 |
81 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
57 |
52 |
$416.00 |
| 81003 |
|
253 |
238 |
$411.72 |
| 81000 |
|
132 |
121 |
$385.06 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
85 |
78 |
$307.76 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
45 |
45 |
$299.58 |
| 92587 |
|
54 |
49 |
$299.30 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
453 |
400 |
$202.04 |
| 90686 |
|
595 |
573 |
$135.85 |
| 90461 |
|
125 |
119 |
$113.67 |
| 86308 |
|
25 |
25 |
$95.28 |
| 96160 |
|
72 |
68 |
$92.07 |
| 97802 |
|
342 |
329 |
$15.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
77 |
72 |
$8.85 |
| 90651 |
|
83 |
80 |
$0.17 |
| 90677 |
|
81 |
79 |
$0.14 |
| 90633 |
|
30 |
28 |
$0.00 |
| 90670 |
|
19 |
16 |
$0.00 |
| 99051 |
|
436 |
407 |
$0.00 |
| 90648 |
|
28 |
25 |
$0.00 |
| 99173 |
|
22 |
19 |
$0.00 |
| 91300 |
|
17 |
12 |
$0.00 |
| 90688 |
|
35 |
33 |
$0.00 |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
252 |
248 |
$0.00 |
| 91307 |
|
127 |
84 |
$0.00 |